Your shopping cart is currently empty

EZH2/HSP90-IN-29 is a potent dual inhibitor of EZH2 and HSP90, with IC50 values of 6.29 nM and 60.1 nM, respectively. It induces cell cycle arrest at the M phase, promotes the expression of genes related to apoptosis/necrosis, and inhibits reactive oxygen species (ROS) catabolism. This compound can cross the blood-brain barrier, making it a promising and easily manageable candidate for glioblastoma (GBM) research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | EZH2/HSP90-IN-29 is a potent dual inhibitor of EZH2 and HSP90, with IC50 values of 6.29 nM and 60.1 nM, respectively. It induces cell cycle arrest at the M phase, promotes the expression of genes related to apoptosis/necrosis, and inhibits reactive oxygen species (ROS) catabolism. This compound can cross the blood-brain barrier, making it a promising and easily manageable candidate for glioblastoma (GBM) research. |
| Molecular Weight | 680.83 |
| Formula | C40H48N4O6 |
| Cas No. | 3033571-35-3 |
| Smiles | O=C(NCC=1C(=O)NC(=CC1C)C)C=2C=C(C=C(C2C)N(CC)C3CCOCC3)C=4C=CC=C(C4)N(C(=O)C=5C=C(C(O)=CC5O)C(C)C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.